stars 1 stars 2 stars 3

Refeyn is pioneering the next era of molecular analysis with mass photometry, a breakthrough technology that weighs individual molecules with light. Our instruments deliver rapid, direct insights into biomolecular function and structure, accelerating discovery and transforming biotherapeutic development. With 1200+ citations, 600+ global installations, and use in Nobel Prize–winning research, Refeyn is shaping the future of scientific innovation.

Refeyn Questions

The Refeyn annual revenue was $23.4 million in 2026.

Fiona Coats is the CMO of Refeyn.

140 people are employed at Refeyn.

Top Refeyn Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users